PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425011
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425011
Anti-retroviral Drugs Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Anti-retroviral Drugs Market size was valued at USD 39,794.2 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.
Antiretroviral drugs are medications used to treat retroviral infections, with HIV (Human Immunodeficiency Virus) being the most prominent example. These drugs work by inhibiting the replication of the virus, thereby slowing down the progression of the disease and reducing the viral load in the body.
Anti-retroviral Drugs Market- Market Dynamics
The increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs is expected to propel the market demand
The growth of the analyzed market is propelled by several key factors, including the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs. For example, in 2022, the HIV Estimates Factsheet for India reported an estimated annual new infection (ANI) of 62.97 thousand cases in 2021. Furthermore, the World Health Organization (WHO) reported in July 2022 that 38.4 million individuals were living with HIV in 2021. The African region, in particular, remains profoundly impacted, with approximately 1 in every 25 adults (3.4%) living with HIV and contributing to over two-thirds of the global HIV-infected population. WHO also highlighted a significant 32.8% increase in HIV cases over the past two decades. Consequently, the growing prevalence of HIV is fueling the demand for antiretroviral drugs.
Moreover, increased investments in R&D by various pharmaceutical companies are a driving force behind the market's growth. As an illustration, in June 2022, GSK (GlaxoSmithKline) announced a substantial EUR 1 billion investment aimed at accelerating R&D activities for the treatment of infectious diseases, particularly those disproportionately affecting lower-income countries. GSK's research endeavors focus on the development of new and innovative vaccines and medications to prevent and treat various diseases, including HIV (via ViiV Healthcare), malaria, tuberculosis, and other infectious diseases. These diseases collectively account for over 60% of the disease burden in many lower-income nations. GSK's Global Health R&D Hubs are advancing with over 30 potential new vaccines and medications, targeting 13 high-burden infectious diseases, including antiretroviral drug research. Consequently, the augmented R&D investments are a significant driving factor behind the expansion of the studied market.
Anti-retroviral Drugs Market- Key Insights
As per the analysis shared by our research analyst, the global Anti-retroviral Drugs Market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)
The Anti-retroviral Drugs Market is projected to grow at a significant rate driven by the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs
Based on product type, the Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) was predicted to show maximum market share in the year 2022
Based on Application, HIV/AIDS was the leading Segment in 2022
On the basis of region, North America was the leading revenue generator in 2022
Anti-retroviral Drugs Market- Segmentation Analysis:
The Global Anti-retroviral Drugs Market is segmented on the basis of Product Type, By Application, and Region.
Based on the type of product, the market is divided into four segments: Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Integrase Inhibitors, and Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors. Within this classification, Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) stand out prominently, offering significant growth potential to this segment. NRTIs function by blocking reverse transcriptase, while NNRTIs bind to and subsequently modify reverse transcriptase. This dual mechanism interferes with the enzyme HIV requires to replicate itself, rendering these two types particularly effective in combating the virus.
The market is categorized by application into four segments: Hepatitis, HIV/AIDS, Herpes, Influenza, and Others. Notably, anti-retroviral drugs find extensive usage in the treatment of HIV/AIDS, primarily due to the substantial global prevalence of this disease. According to reports from the US Department of Health & Human Services, approximately 37.2 million individuals worldwide are grappling with HIV/AIDS.
Anti-retroviral Drugs Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Anti-retroviral Drugs Market- Competitive Landscape:
In the field of antiretroviral drugs, companies are primarily focused on research, development, and commercialization. They work on discovering and producing new antiretroviral therapies, improving existing medications, and conducting clinical trials to assess the safety and efficacy of these drugs. Additionally, pharmaceutical companies often collaborate with healthcare organizations and government agencies to expand access to antiretroviral treatments in affected regions.
Recent Developments:
In September 2022, Merck announced the commencement of a new phase 3 clinical trial to assess the efficacy of once-daily oral islatravir for the treatment of HIV-1 infection.
In August 2022, Gilead obtained global regulatory approval for Sunlenca (Lenacapavir), a unique twice-yearly treatment option for HIV.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTI-RETROVIRAL DRUGS MARKET KEY PLAYERS
- AbbVie Inc.
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd
- Gilead Sciences, Inc.
- Merck & Co, Inc.
- Viatris Inc. (Mylan Inc.)
- GlaxoSmithKline plc (ViiV Healthcare)
- Cipla Inc.
- Johnson and Johnson
GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY PRODUCT TYPE
- Protease Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Integrase Inhibitors
- Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY APPLICATION
- Hepatitis
- HIV/AIDS
- Herpes
- Influenza
- Others
GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Anti-retroviral Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Anti-retroviral Drugs Market Snippet by Product Type
- 2.1.2. Anti-retroviral Drugs Market Snippet by Application
- 2.1.3. Anti-retroviral Drugs Market Snippet by Country
- 2.1.4. Anti-retroviral Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. Anti-retroviral Drugs Key Market Trends
- 3.1. Anti-retroviral Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Anti-retroviral Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Anti-retroviral Drugs Market Opportunities
- 3.4. Anti-retroviral Drugs Market Future Trends
4. Anti-retroviral Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Anti-retroviral Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Anti-retroviral Drugs Market Landscape
- 6.1. Anti-retroviral Drugs Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Anti-retroviral Drugs Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
- 7.1.2. Protease Inhibitors
- 7.1.3. Non-Nucleoside Reverse Transcriptase Inhibitors
- 7.1.4. Integrase Inhibitors
- 7.1.5. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
8. Anti-retroviral Drugs Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Hepatitis
- 8.1.3. HIV/AIDS
- 8.1.4. Herpes
- 8.1.5. Influenza
- 8.1.6. Others
9. Anti-retroviral Drugs Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Anti-retroviral Drugs Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Anti-retroviral Drugs Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Anti-retroviral Drugs Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Anti-retroviral Drugs Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Anti-retroviral Drugs Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Anti-retroviral Drugs Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. AbbVie Inc.
- 10.2.2. Boehringer Ingelheim International GmbH
- 10.2.3. Bristol-Myers Squibb Company
- 10.2.4. F. Hoffmann-La Roche Ltd
- 10.2.5. Gilead Sciences, Inc.
- 10.2.6. Merck & Co, Inc.
- 10.2.7. Viatris Inc. (Mylan Inc.)
- 10.2.8. GlaxoSmithKline plc (ViiV Healthcare)
- 10.2.9. Cipla Inc.
- 10.2.10. Johnson and Johnson
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Anti-retroviral Drugs Market: Product Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Product Type
- TABLE Global Anti-retroviral Drugs Market, by Product Type 2018-2030 (USD Million)
- TABLE Anti-retroviral Drugs Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Anti-retroviral Drugs Market, by Application 2018-2030 (USD Million)
- TABLE Anti-retroviral Drugs Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Anti-retroviral Drugs Market, by Region 2018-2030 (USD Million)
- TABLE North America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE North America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
- TABLE North America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
- TABLE Europe Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
- TABLE Latin America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
List of Figures
- FIGURE Anti-retroviral Drugs Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Product Type segment market share analysis, 2022 & 2030
- FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Application segment market share analysis, 2022 & 2030
- FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Anti-retroviral Drugs Market share and leading players, 2022
- FIGURE Europe Anti-retroviral Drugs Market share and leading players, 2022
- FIGURE Asia Pacific Anti-retroviral Drugs Market share and leading players, 2022
- FIGURE Latin America Anti-retroviral Drugs Market share and leading players, 2022
- FIGURE Middle East and Africa Anti-retroviral Drugs Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Anti-retroviral Drugs Market share analysis by country, 2022
- FIGURE Germany Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Anti-retroviral Drugs Market share analysis by country, 2022
- FIGURE India Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Anti-retroviral Drugs Market share analysis by country, 2022
- FIGURE Brazil Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Anti-retroviral Drugs Market share analysis by country, 2022
- FIGURE Saudi Arabia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
